| Source Date | Board Meeting Date | Details |
|
22-May-2025
|
30-May-2025
|
Final Dividend & Audited Results
|
|
21-Apr-2025
|
23-Apr-2025
|
Scheme of Arrangement & Inter alia, to consider and approved the Scheme of Amalgamation ( Scheme ) between Eulogia Inn Private Limited (the Transferor Company) with Praveg Limited (the Transferee Company), and their respective shareholders and Creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ( the Act ) and other applicable laws including the rules and regulations which envisages the amalgamation of Eulogia Inn Private Limited into and with Praveg Limited; ( Proposed Transaction ).
|
|
03-Feb-2025
|
11-Feb-2025
|
Quarterly Results & Employees Stock Option Plan
|
|
05-Nov-2024
|
14-Nov-2024
|
Quarterly Results
|
|
05-Aug-2024
|
10-Aug-2024
|
Quarterly Results & the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2024. Further to intimation dated June 26, 2024, relating to Closure of Trading Window, the Trading Window for dealing in securities of the Company shall remain closed till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2024.
|
|
21-May-2024
|
27-May-2024
|
Final Dividend & Audited Results
|
|
01-Apr-2024
|
04-Apr-2024
|
Preferential Issue of shares & Inter alia, to consider and approve:- (1) proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights / qualified institutional placement or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
|
05-Feb-2024
|
13-Feb-2024
|
Quarterly Results
|
|
20-Dec-2023
|
26-Dec-2023
|
Preferential Issue of shares & Inter-alia, to discuss, consider and evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
|
02-Nov-2023
|
09-Nov-2023
|
Quarterly Results
|